Table 1. Summary of baseline characteristics of PLHIV in 13 outpatient clinics in Vietnam [N = 3,449].
| Characteristics | Patients who died within six months of ART | Patients who were lost to follow up during study period | Total PLHIV | |
| N = 198n (%) | N = 530n (%) | N = 3,449n (%) | ||
| Baseline age years mean (SD) | 29.5 (5.8) | 29.2 (6.0) | 30.3 (6.6) | |
| Gender | Male | 141 (71.2) | 426 (80.4) | 2,573 (74.6) |
| Female | 57 (28.8) | 104 (19.6) | 876 (25.4) | |
| Baseline CD4 | <50 | 99 (50.0) | 305 (57.5) | 1,538 (44.6) |
| (cells/mm3) | 50–100 | 72 (36.4) | 82 (15.5) | 503 (14.6) |
| 100–200 | 20 (10.1) | 87 (16.4) | 649 (18.8) | |
| 200–350 | 1 (0.5) | 38 (7.2) | 320 (9.3) | |
| 350–500 | 0 (0.0) | 10 (1.9) | 53 (1.5) | |
| >500 | 0 (0.0) | 4 (0.8) | 43 (1.2) | |
| Missing | 6 (3.0) | 4 (0.8) | 343 (9.9) | |
| ART initiation year | 2005 | 62 (31.3) | 23 (4.3) | 105 (3.0) |
| 2006 | 47 (23.7) | 123 (23.2) | 497 (14.4) | |
| 2007 | 38 (19.2) | 128 (24.2) | 891 (25.8) | |
| 2008 | 26 (13.1) | 151 (28.5) | 966 (28.0) | |
| 2009 | 14 (7.1) | 89 (16.8) | 843 (24.4) | |
| Missing | 11 (5.6) | 16 (3.0) | 147 (4.3) | |
| History of IDUa | Yes | 152 (76.8) | 380 (71.7) | 2,250 (65.2) |
| No | 43 (21.7) | 98 (18.5) | 937 (27.2) | |
| Missing | 3 (1.5) | 52 (9.8) | 262 (7.6) | |
| History of USSb | Yes | 78 (39.4) | 124 (23.4) | 1,070 (31.0) |
| No | 107 (54.0) | 358 (67.5) | 2,270 (65.8) | |
| Missing | 13 (6.6) | 48 (9.1) | 109 (3.2) | |
| Baseline BMIc kg/m2 | 13.92 (7.3) | 16.33 (6.1) | 16.63 (8.4) | |
| Baseline OId | Yes | 128 (64.6) | 364 (68.7) | 1,962 (56.9) |
| No | 49 (24.7) | 134 (25.3) | 1,191 (34.5) | |
| Missing | 21 (10.6) | 32 (6.0) | 296 (8.6) | |
| Baseline CTXe | Yes | 107 (54.0) | 372 (70.2) | 2,115 (61.3) |
| No | 82 (41.5) | 124 (23.4) | 916 (26.6) | |
| Missing | 9 (4.5) | 34 (6.4) | 418 (12.1) | |
| Baseline TBf | Yes | 150 (75.8) | 398 (75.1) | 1,121 (32.5) |
| No | 41 (20.7) | 113 (21.3) | 2,091 (60.6) | |
| Missing | 7 (3.5) | 19 (3.6) | 237 (6.9) | |
| Baseline WHO stage | Stage I | 8 (4.0) | 8 (1.5) | 76 (2.2) |
| Stage II | 24 (12.1) | 54 (10.2) | 434 (12.6) | |
| Stage III | 38 (19.2) | 74 (14.0) | 692 (20.1) | |
| Stage IV | 109 (55.1) | 378 (71.3) | 1,919(55.6) | |
| Missing | 19 (9.6) | 16 (3.0) | 328 (9.5) | |
| Adherence | Poor | 81 (40.9) | 425 (80.2) | 975 (28.3) |
| Good | 105 (53.0) | 78 (14.7) | 2,145 (62.2) | |
| Missing | 12 (6.1) | 27 (5.1) | 329 (9.5) | |
a
: IDU: Injecting drug user, b: USS: Unsafe sex, c: BMI: Body mass index, d: OI: Opportunistic infection, e: CTX:
Cotrimoxazol use, f: TB: Tuberculosis.